FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3139194731> ?p ?o ?g. }

• W3139194731 endingPage "767" @default.
• W3139194731 startingPage "758" @default.
• W3139194731 abstract "Background: Tenofovir-based antiretroviral therapy (ART) has become first-line in all major HIV treatment guidelines. Compared with tenofovir disoproxil fumarate (TDF), tenofovir alafenamide (TAF) has a favorable renal and bone safety profile, but concerns about metabolic complications remain. Objective: To assess weight changes, the development of overweight/obesity, and changes in lipid levels 18 months after replacing TDF with TAF. Design: Cohort study. Setting: 5 university hospitals, affiliated hospitals, and private physicians in Switzerland. Participants: 4375 adults living with HIV who received TDF-containing ART for 6 months or longer. Measurements: Changes in weight and lipid levels were assessed using mixed-effect models. Differences in proportions of newly overweight/obese participants were calculated using 2-proportions Z tests. Results: 4375 individuals were included, with follow-up between 1 January 2016 and 31 July 2019. Median age was 50 years (interquartile range, 43 to 56 years), 25.9% were female, and 51.7% had a normal body mass index (BMI); 3484 (79.6%) switched to TAF and 891 (20.4%) continued TDF. After 18 months, switching to TAF was associated with an adjusted mean weight increase of 1.7 kg (95% CI, 1.5 to 2.0 kg), compared with 0.7 kg (CI, 0.4 to 1.0 kg) with the continued use of TDF (between-group difference, 1.1 kg [CI, 0.7 to 1.4 kg]). Among individuals with a normal BMI, 13.8% who switched to TAF became overweight/obese, compared with 8.4% of those continuing TDF (difference, 5.4 percentage points [CI, 2.1 to 8.8 percentage points]). Switching to TAF led to increases in adjusted mean total cholesterol (0.25 mmol/L [9.5 mg/dL]), high-density lipoprotein cholesterol (0.05 mmol/L [1.9 mg/dL]), low-density lipoprotein cholesterol (0.12 mmol/L [4.7 mg/dL]), and triglyceride (0.18 mmol/L [16.1 mg/dL]) levels after 18 months. Limitation: Short follow-up, small subgroup analyses, and potential residual confounding. Conclusion: Replacing TDF with TAF is associated with adverse metabolic changes, including weight increase, development of obesity, and worsening serum lipid levels. Primary Funding Source: Swiss National Science Foundation." @default.
• W3139194731 created "2021-03-29" @default.
• W3139194731 creator A5003503698 @default.
• W3139194731 creator A5011217027 @default.
• W3139194731 creator A5026249646 @default.
• W3139194731 creator A5028829460 @default.
• W3139194731 creator A5029269504 @default.
• W3139194731 creator A5035277716 @default.
• W3139194731 creator A5039985712 @default.
• W3139194731 creator A5053142701 @default.
• W3139194731 creator A5059371192 @default.
• W3139194731 creator A5070278395 @default.
• W3139194731 creator A5085277275 @default.
• W3139194731 creator A5088187599 @default.
• W3139194731 creator A5088630101 @default.
• W3139194731 date "2021-06-01" @default.
• W3139194731 modified "2023-10-12" @default.
• W3139194731 title "Weight and Metabolic Changes After Switching From Tenofovir Disoproxil Fumarate to Tenofovir Alafenamide in People Living With HIV" @default.
• W3139194731 cites W1962312697 @default.
• W3139194731 cites W1964217313 @default.
• W3139194731 cites W1965866264 @default.
• W3139194731 cites W1983201600 @default.
• W3139194731 cites W2004993190 @default.
• W3139194731 cites W2088150442 @default.
• W3139194731 cites W2113255660 @default.
• W3139194731 cites W2144095981 @default.
• W3139194731 cites W2149185709 @default.
• W3139194731 cites W2149812642 @default.
• W3139194731 cites W2162761942 @default.
• W3139194731 cites W2196190612 @default.
• W3139194731 cites W2606524050 @default.
• W3139194731 cites W2724491646 @default.
• W3139194731 cites W2794800108 @default.
• W3139194731 cites W2893518254 @default.
• W3139194731 cites W2894848321 @default.
• W3139194731 cites W2915372808 @default.
• W3139194731 cites W2962964639 @default.
• W3139194731 cites W2979917028 @default.
• W3139194731 cites W3005312287 @default.
• W3139194731 cites W3011201914 @default.
• W3139194731 cites W3016600481 @default.
• W3139194731 cites W3045256412 @default.
• W3139194731 doi "https://doi.org/10.7326/m20-4853" @default.
• W3139194731 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33721521" @default.
• W3139194731 hasPublicationYear "2021" @default.
• W3139194731 type Work @default.
• W3139194731 sameAs 3139194731 @default.
• W3139194731 citedByCount "59" @default.
• W3139194731 countsByYear W31391947312021 @default.
• W3139194731 countsByYear W31391947312022 @default.
• W3139194731 countsByYear W31391947312023 @default.
• W3139194731 crossrefType "journal-article" @default.
• W3139194731 hasAuthorship W3139194731A5003503698 @default.
• W3139194731 hasAuthorship W3139194731A5011217027 @default.
• W3139194731 hasAuthorship W3139194731A5026249646 @default.
• W3139194731 hasAuthorship W3139194731A5028829460 @default.
• W3139194731 hasAuthorship W3139194731A5029269504 @default.
• W3139194731 hasAuthorship W3139194731A5035277716 @default.
• W3139194731 hasAuthorship W3139194731A5039985712 @default.
• W3139194731 hasAuthorship W3139194731A5053142701 @default.
• W3139194731 hasAuthorship W3139194731A5059371192 @default.
• W3139194731 hasAuthorship W3139194731A5070278395 @default.
• W3139194731 hasAuthorship W3139194731A5085277275 @default.
• W3139194731 hasAuthorship W3139194731A5088187599 @default.
• W3139194731 hasAuthorship W3139194731A5088630101 @default.
• W3139194731 hasConcept C119060515 @default.
• W3139194731 hasConcept C126322002 @default.
• W3139194731 hasConcept C142462285 @default.
• W3139194731 hasConcept C203014093 @default.
• W3139194731 hasConcept C2779778239 @default.
• W3139194731 hasConcept C2780221984 @default.
• W3139194731 hasConcept C2780586474 @default.
• W3139194731 hasConcept C2911190787 @default.
• W3139194731 hasConcept C2993143319 @default.
• W3139194731 hasConcept C3013748606 @default.
• W3139194731 hasConcept C511355011 @default.
• W3139194731 hasConcept C71924100 @default.
• W3139194731 hasConcept C72563966 @default.
• W3139194731 hasConceptScore W3139194731C119060515 @default.
• W3139194731 hasConceptScore W3139194731C126322002 @default.
• W3139194731 hasConceptScore W3139194731C142462285 @default.
• W3139194731 hasConceptScore W3139194731C203014093 @default.
• W3139194731 hasConceptScore W3139194731C2779778239 @default.
• W3139194731 hasConceptScore W3139194731C2780221984 @default.
• W3139194731 hasConceptScore W3139194731C2780586474 @default.
• W3139194731 hasConceptScore W3139194731C2911190787 @default.
• W3139194731 hasConceptScore W3139194731C2993143319 @default.
• W3139194731 hasConceptScore W3139194731C3013748606 @default.
• W3139194731 hasConceptScore W3139194731C511355011 @default.
• W3139194731 hasConceptScore W3139194731C71924100 @default.
• W3139194731 hasConceptScore W3139194731C72563966 @default.
• W3139194731 hasFunder F4320320924 @default.
• W3139194731 hasIssue "6" @default.
• W3139194731 hasLocation W31391947311 @default.
• W3139194731 hasOpenAccess W3139194731 @default.
• W3139194731 hasPrimaryLocation W31391947311 @default.
• W3139194731 hasRelatedWork W1866091461 @default.
• W3139194731 hasRelatedWork W2000335303 @default.

• next